Abbott Laboratories ABT
$102.83
+0.58%
at last close
Market Cap$176.90 billion
P/E Ratio33.28
Div Yield2.45%
Volume4.52M
52-Week Range
$81.97$137.49
Analyst Ratings
- Consensus
- Buy — 20 Buy · 0 Hold · 0 Sell (20 analysts)
- Avg. Price Target
- $125.00 (+21.6% upside)
Key Stats
- Today's Range
- $101.50 – $103.00
- 50-Day Range
- $87.64 – $117.34
- 52-Week Range
- $81.97 – $137.49
- Volume
- 4.52 million shs
- Average Volume
- 7.45 million shs
- Market Cap
- $176.90 billion
- P/E Ratio
- 33.28
- Dividend Yield
- 2.45%
Valuation
- P/E Ratio
- 33.28
- Price / Book
- 3.42
- Price / Sales
- 3.80
Dividend
- Dividend Yield
- 2.45%
- Annual Dividend
- $2.52
- Payout Ratio
- 81.55%
- Ex-Dividend Date
- 2026-10-15
Short Interest
- Short Interest
- 0.57%
- Days to Cover
- 1.68
Financials (TTM)
- Revenue
- $46.59 billion
- Net Income
- $5.42 billion
- Net Margin
- 11.65%
- Return on Equity
- 10.48%
- Debt-to-Equity
- —
About Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Related Stocks
Compare head-to-head: ABT vs LLY·ABT vs JNJ·ABT vs ABBV·ABT vs PFE
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.